U.S. FDA advisory panel to discuss COVID-19 vaccine boosters on Sept. 17

(Reuters) – The U.S. Food and Drug Administration said on Wednesday its outside advisers will meet on Sept. 17 to discuss additional doses of COVID-19 vaccines and specifically Pfizer Inc and partner BioNTech’s application for the use of a booster vaccine dose.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)